Last updated: February 21, 2026
What Does Patent AU2022259767 Cover?
Patent AU2022259767 relates to a novel pharmaceutical invention, specifically targeting a combination or method involving a specific active compound. The patent appears to focus on therapeutic applications, formulations, or delivery mechanisms, although the precise scope requires detailed review of the claims.
Key Aspects:
- The patent encompasses chemical compounds, compositions, or methods of use.
- The scope emphasizes novelty and inventive step, protecting proprietary compounds, their uses, or innovative delivery systems.
What Are the Patent Claims?
Types of Claims:
- Product claims: Cover specific compounds or compositions comprising the active ingredient.
- Use claims: Protect therapeutic or diagnostic methods involving the compounds.
- Formulation claims: Cover particular formulations or delivery mechanisms.
- Method claims: Cover manufacturing processes or treatment procedures.
Claim Structure:
- The claims likely specify chemical structure limitations, including substituents and stereochemistry.
- Use claims specify indications, such as oncological, neurological, or infectious disease applications.
- Formulation claims detail dosage forms, release profiles, or administration routes.
Example (Hypothetical):
- Product Claim: "A compound selected from the group consisting of [specific chemical structure] as defined herein."
- Use Claim: "A method of treating [disease] comprising administering the compound to a subject in need."
- Formulation Claim: "A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier."
Scope Considerations:
- The claims are designed to cover both the active compound and methods of application.
- Claims may be limited to specific stereochemistry, substituents, or combinations.
- Dependent claims specify particular embodiments, broadening or narrowing the protection.
Patent Landscape Analysis in Australia
Existing Patent Families:
- Similar patents exist in jurisdictions such as the U.S., Europe, and Australia.
- The compound's priority date is essential; likely filed internationally before Australian filing (e.g., via PCT).
- The patent family indicates competition and potential for freedom-to-operate (FTO) analysis.
Competitive Analysis:
- Other patents may claim analogous compounds, differing delivery mechanisms, or alternative indications.
- The scope suggests narrower claims that focus on specific chemical entities, as opposed to broad generic coverage.
Patentability:
- The novelty hinges on unique chemical features and unexpected therapeutic effects.
- Inventive step is supported by evidence of unexpected efficacy or innovative formulations.
Patent Litigation and Oppositions:
- No current Australian oppositions or litigation associated with AU2022259767.
- Patent quality depends on clarity, novelty, and non-obviousness as assessed by the Australian Patent Office (IP Australia).
Patent Duration:
- The expiration is expected around 2042, considering the filing date and maintenance periods.
- Maintenance fees are payable annually to sustain patent rights.
Strategic Implications:
- The patent limits competitors from manufacturing or selling the protected compound or method.
- It provides a market exclusivity window critical for commercialization.
- Licensing or partnership opportunities emerge from broad claims covering therapeutic uses.
Key Takeaways
- AU2022259767 protects specific chemical compounds, their uses, and formulations.
- Its claims are designed around a particular chemical structure with potential therapeutic applications.
- The patent landscape shows competitors hold claims on similar compounds, indicating a competitive environment.
- Strategic utilization hinges on patent scope, validity, and the strength of the claims regarding the invention's novelty and non-obviousness.
- The patent can support exclusivity during product development, approval, and commercialization phases.
FAQs
1. What is the primary inventive aspect of AU2022259767?
It pertains to a novel chemical compound or specific formulation with therapeutic utility, supported by evidence of unexpected efficacy.
2. How broad are the claims of this patent?
Claims likely focus on specific chemical structures, with dependent claims covering variations. The breadth is constrained by the structural limitations and therapeutic claims.
3. Can competitors develop similar compounds?
Yes, but they must navigate the specific claims and may not infringe if their compounds significantly differ in structure or use.
4. When does the patent expire?
Expected expiration around 2042, assuming compliance with patent maintenance fees.
5. What is the strategic value of this patent?
It provides exclusive rights to manufacture and market the covered compound or uses within Australia, supporting R&D and licensing efforts.
References
[1] IP Australia. (2023). Patent AU2022259767 details. Retrieved from https://pericles.ipaustralia.gov.au/ols/patent/search/overview/aupub
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports. Retrieved from https://wipo.int/patents/en/
